HIF1A and neoplasm: These treatment strategies may involve targeting glucose supply, which can have toxic effects on tumor cells in the hypoxic TME [240], or inhibiting key enzymes in the glycolytic pathway, including glucose transporters, HIF-1α, and the mTOR pathway [241–243].